HTDS helps Kenya with its war on counterfeit medicine

25 April 2019 ─  /  Analytical Sciences  by

The counterfeit drug industry leads to hundreds of thousands of deaths every year mostly in developing countries but also in developed countries. At the end of last year, in Kenya, the national drug control laboratory (SBP) started hunting for a solution and made a deal to acquire two TruScan GP units with HTDS. With counterfeit and substandard medicines being a problem that must be controlled in Kenya, the portable solution which can be used in the field or laboratory was very appealing.

TruScan GP is a portable Raman Spectrometer designed to qualitatively determine whether a drug is genuine or substandard. Its non-destructive analysis approach is perfect for inspection of already packaged drugs and the rapid anaylsis time does not have an effect on slowing down the production line – the perfect solution to Kenya’s problem!

In the national papers, two articles have already been published in regards to the excitement surrounding this product in Kenya. Fred Siyoi, the SCH Clerk said “The Handheld Raman Spectrometer is the first in the country and will go a long way in boosting the fight against poor quality drugs”. Clearly happy with the TruScan GP devices the PPB are now looking for this type of control.

Good luck and congratulations to Joseph Kimari and the rest of the HTDS team for their hard work on this project!


Read also...

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

23 September 2025

Analytical Sciences

HTDS becomes official distributor of Oxford Nanopore Technologies solutions

HTDS is pleased to announce the signing of a strategic partnership with Oxford Nanopore Technologies, a UK-based company that is a pioneer and globally recognized for its DNA and RNA sequencing solutions. This new agreement allows HTDS to strengthen its portfolio of analytical solutions and offer its customers a breakthrough technology that is transforming genomic and biological research. Oxford Nanopore : a unique technology to analyze lifeWith the mission to enable “the analysis of anything, by anyone, anywhere”, Oxford Nanopore has developed an innovative sequencing technology based on nanopores.This approach provides researchers and industry professionals with real-time, accurate, flexible, and scalable nucleic acid analysis, opening new perspectives in: Plant and animal genomicsAgriculture and food sciencesEnvironmental research and conservationAlready adopted in more than 125 countries, this technology is revolutionizing our understanding of life and accelerating scientific progress. A complete range of solutions tailored to every projectThrough this partnership, HTDS now distributes the entire Oxford Nanopore portfolio, covering all needs, from individual research to large-scale projects:MinION™ : a portable, personal sequencer, ideal for generating rapid data directly in the field or in the lab.GridION™ : a flexible benchtop sequencer, integrating data processing for multiple simultaneous analyses.PromethION™ (P2 Solo, P2 Integrated, PromethION 24) : a high-throughput platform for projects requiring massive volumes of genomic data.ElysION™ : a fully automated solution, from sample preparation to data analysis.In addition to these platforms, Oxford Nanopore provides a complete sequencing ecosystem, including flow cells and sample preparation kits, as well as control and analysis software such as MinKNOW™ and EPI2ME™, making sequencing accessible even to researchers without bioinformatics expertise. HTDS : a trusted partner for your genomics projectsBy partnering with Oxford Nanopore, HTDS reaffirms its commitment to offering its customers the most innovative technologies to meet their scientific and industrial needs.Research laboratories, academic centers, and industry players will now benefit from powerful, scalable, and tailored tools to address today’s challenges in genomics, health, and the environment.